USPTO Examiner SOLOMON JOSHUA BRENDON - Art Unit 3792

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18908264DEFIBRILLATION ASSEMBLY ENERGIZABLE THROUGH PAD REMOVALOctober 2024April 2025Allow710NoNo
18673523SYSTEM AND METHOD FOR STIMULATION OF NERVE TISSUEMay 2024April 2025Allow1010NoNo
18672813COMPOSITIONS AND METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDSMay 2024April 2025Allow1010NoNo
18630185THIN FILM ELECTRODE ASSEMBLYApril 2024March 2025Allow1110NoNo
18612930ANTENNA ASSEMBLY FOR SUPPLYING POWER TO AN IMPLANTABLE NEURAL STIMULATOR DEVICEMarch 2024May 2025Allow1410NoNo
18591811MULTI-CABLE MEDICAL INSTRUMENTFebruary 2024January 2025Allow1110YesNo
18420914BLOOD PUMP WITH FLOW CANNULAJanuary 2024March 2025Allow1420YesNo
18410532WEARABLE DEFIBRILLATOR SYSTEM FORWARDING PATIENT INFORMATION BASED ON RECIPIENT PROFILE AND/OR EVENT TYPEJanuary 2024December 2024Allow1110NoNo
18399547SYSTEM AND METHOD FOR AUTOMATIC VAGUS NERVE STIMULATION FOR POST-STROKE REHABILITATIONDecember 2023July 2024Allow700NoNo
18526789Compositions And Methods Of Altering The Electric Impedance To An Alternating Electric FieldDecember 2023April 2025Allow1720NoNo
18522525Systems and Methods for Performing an Intraocular Procedure for Treating an Eye ConditionNovember 2023March 2025Allow1610NoNo
18486722Use Of Cold Atmospheric Pressure Plasma To Treat WartsOctober 2023February 2025Allow1620NoNo
18485601SINGLE SITE ROBOTIC DEVICE AND RELATED SYSTEMS AND METHODSOctober 2023August 2024Allow1010NoNo
18482995SYSTEM AND METHOD FOR COLLECTING AND DISPLAYING DATA ACQUIRED FROM AN IMPLANTABLE THERAPY DEVICE USING A CONSUMER ELECTRONIC DEVICEOctober 2023March 2025Allow1720NoNo
18483265METHODS AND SYSTEMS FOR TARGET LOCALIZATION AND DBS THERAPYOctober 2023August 2024Allow1010NoNo
18374759Needle-Array Devices and Related MethodsSeptember 2023October 2024Allow1310NoNo
18475136IMPLANTS USING ULTRASONIC COMMUNICATION FOR MODULATING SPLENIC NERVE ACTIVITYSeptember 2023August 2024Allow1010NoNo
18469271MASK PAD HAVING ELECTRICAL MUSCLE STIMULATION ELECTRODE PADSeptember 2023April 2024Allow700NoNo
18469274ELECTRICAL MUSCLE STIMULATION METHOD USING THE ELECTRICAL MUSCLE SIMULATION ELECTRODE PADSeptember 2023August 2024Allow1010NoNo
18469331FIXATION COMPONENTS FOR IMPLANTABLE MEDICAL DEVICESSeptember 2023December 2024Abandon1510NoNo
18368876Delivering Tumor Treating Fields (TTFields) Using Implantable Transducer ArraysSeptember 2023December 2024Allow1520NoNo
18211328APPARATUS AND METHOD FOR NON-INVASIVE FRACTIONAL TREATMENT OF SKIN TISSUEJune 2023April 2024Allow1010NoNo
18325770INTRODUCER SHEATH ASSEMBLY FOR CATHETER SYSTEMS AND METHODS OF USING SAMEMay 2023January 2024Allow810NoNo
18140158PERSONALIZATION OF EXCIMER LASER FIBERSApril 2023November 2024Allow1920YesNo
18308348LEAD INTEGRITY AND CLOSED-LOOP ALGORITHM DIAGNOSTICApril 2023March 2024Allow1110YesNo
18139139ENHANCED FIBER PROBES FOR ELTApril 2023March 2024Allow1010NoNo
18132941TRANSCATHETER ELECTRODE ARRAY AND USE THEREOFApril 2023February 2024Allow1010YesNo
18185158NEEDLE TIP FOR APPLICATION OF CURRENT, HAND PIECE, AND SKIN TREATMENT APPARATUSMarch 2023August 2023Allow510NoNo
18180705OBSTRUCTIVE AND CENTRAL SLEEP APNEA COMBINATION THERAPY CONTROLMarch 2023October 2023Allow810YesNo
18178669METHOD AND APPARATUS FOR ELECTRICAL CURRENT THERAPY OF BIOLOGICAL TISSUE AND INSULIN RELEASE THEREFROMMarch 2023February 2024Allow1110NoNo
18109539Delivering Tumor Treating Fields (TTFields) Using Implantable Transducer ArraysFebruary 2023June 2023Allow400NoNo
18100728SYSTEMS AND METHODS FOR THERAPEUTIC APPLICATION OF ENERGYJanuary 2023December 2023Allow1120YesNo
18096038BLOOD PUMP WITH FLOW CANNULAJanuary 2023October 2023Allow910NoNo
18090591ANTENNA ASSEMBLY FOR SUPPLYING POWER TO AN IMPLANTABLE NEURAL STIMULATOR DEVICEDecember 2022October 2023Allow910NoNo
18013829TRANSCATHETER ELECTRODE ARRAY AND USE THEREOFDecember 2022September 2023Allow810YesNo
18148171DETERMINING QUALITY OF ELECTRODE CONTACT WITH SKIN SURFACEDecember 2022May 2024Abandon1610NoNo
18086224IMPLANTABLE MEDICAL DEVICES HAVING MODULAR LEAD BORESDecember 2022August 2023Allow810NoNo
18058904SINGLE SITE ROBOTIC DEVICE AND RELATED SYSTEMS AND METHODSNovember 2022July 2023Allow810NoNo
18055736MONITORING EQUIPMENT AND MONITORING METHOD THEREOFNovember 2022May 2025Allow3000NoNo
17986660LOW ENERGY IMPLANTABLE DEVICES AND METHODS OF USENovember 2022December 2024Allow2521NoNo
17985896Method and device for improving brain functionNovember 2022March 2024Abandon1620NoNo
17983810METHOD AND APPARATUS FOR FILTERINGNovember 2022October 2024Allow2310NoNo
18053506MICRO-PULSED LIQUID SPRAY FOR COOLINGNovember 2022March 2024Allow1620NoNo
17921961ELECTRODE WIRE FOR APPLYING ELECTRICAL STIMULATION TO BODY ORGANS, AND ELECTRODE SYSTEM USING SAMEOctober 2022January 2025Allow2600NoNo
17971102SYSTEMS AND METHODS FOR PERFORMING AN INTRAOCULAR PROCEDURE FOR TREATING AN EYE CONDITIONOctober 2022August 2023Allow1010YesNo
17942330TELESCOPING MEDICAL DEVICE ASSEMBLY AND STERILE DRAPESeptember 2022July 2024Allow2320NoNo
17942910Delivering Tumor Treating Fields (TTFields) Using Implantable Transducer ArraysSeptember 2022February 2023Allow510NoNo
17930645OBSTRUCTIVE AND CENTRAL SLEEP APNEA COMBINATION THERAPY CONTROLSeptember 2022February 2023Allow510NoNo
17939105TREATMENT ASSEMBLY FOR PROVIDING TUMOR TREATING FIELDS TO ANIMAL TEST SUBJECTSSeptember 2022April 2024Allow2030NoNo
17799894QUALITY ASSURANCE APPARATUS AND METHOD FOR CANCER TREATMENT SYSTEM WITH ELECTRIC FIELDAugust 2022September 2024Allow2510NoNo
17886345APPARATUSES FOR DELIVERING TUMOR TREATING FIELDS HAVING ELECTRODE ELEMENTS WITH NONUNIFORM THICKNESSES AND METHODS FOR MANUFACTURING SAMEAugust 2022January 2025Allow2910NoNo
17884208TREATMENT INSTRUMENT, TREATMENT SYSTEM, AND CONTROL METHODAugust 2022June 2025Allow3510YesNo
17868935MASK INSTRUMENT AND METHOD FOR USING THE SAMEJuly 2022September 2024Allow2610NoNo
17865531CRYOPROBE FOR MINIMALLY INVASIVE CARDIAC ABLATION WITH A FUNCTIONAL TIPJuly 2022March 2025Allow3200NoNo
17860231BIOLOGICAL DATA TRACKING SYSTEM AND METHODJuly 2022February 2025Abandon3140NoNo
17842971ENHANCED FIBER PROBES FOR ELTJune 2022February 2023Allow810NoNo
17841968COMPOSITIONS AND METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDSJune 2022January 2024Allow1911NoNo
17832271INDEPENDENTLY IMPLANTABLE SENSORS FOR ORTHOPEDIC IMPLANTSJune 2022April 2025Allow3410NoNo
17752612CRYOABLATION ICEBALL FORMATION MONITORING DEVICES, SYSTEMS, AND METHODSMay 2022March 2025Allow3400NoNo
17748091AUTOMATIC CONTROL OF PHACOEMULSIFICATION NEEDLE TRAJECTORYMay 2022May 2025Allow3610NoNo
17745821DEVICES FOR PUMPING BLOOD, RELATED SYSTEMS, AND RELATED METHODSMay 2022November 2024Allow3030NoNo
17741717APPARATUSES, SYSTEMS, AND METHODS FOR THE TREATMENT OF DAMAGED TISSUEMay 2022May 2025Allow3610NoNo
17706528SYSTEMS AND METHODS FOR CONTROLLING BLOOD PRESSUREMarch 2022January 2023Allow1010YesNo
17702665TRANSVAGINAL TREATMENT OF STRESS URINARY INCONTINENCEMarch 2022June 2024Allow2610NoNo
17697976NANOPARTICLES FOR USE FOR TREATING A NEURONAL DISORDERMarch 2022April 2023Allow1210NoNo
17653814METHODS AND SYSTEMS FOR TARGET LOCALIZATION AND DBS THERAPYMarch 2022July 2023Allow1610YesNo
17686542Uploading Data from an Isolated System without Compromising IsolationMarch 2022October 2022Allow700NoNo
17652836ELECTRICAL STIMULATION MODULATIONFebruary 2022August 2023Allow1710NoNo
17753135Management of Compliance Voltage for a Stimulator DeviceFebruary 2022April 2025Allow3820YesNo
17674108METHOD AND APPARATUS FOR DETERMINING BRONCHIAL DENERVATIONFebruary 2022April 2025Allow3710YesNo
17590950Endoscopically Guided Ablation Catheters with Thermally Resistant BalloonsFebruary 2022March 2025Allow3710NoNo
17632341MICROCURRENT PATCHFebruary 2022September 2023Allow1910NoNo
17631950TEMPERATURE-CONTROLLABLE CRYOABLATION SYSTEMFebruary 2022May 2025Abandon4010NoNo
17590694METHODS FOR TREATING SKIN DISORDERS USING PRECISION COOLING TECHNOLOGYFebruary 2022March 2025Allow3710NoNo
17580298SPLIT ROBOTIC REFERENCE FRAME FOR NAVIGATIONJanuary 2022June 2025Allow4010YesNo
17626787OCULAR THERAPY MODES AND SYSTEMSJanuary 2022November 2023Allow2210NoNo
17647680SYSTEMS AND METHODS FOR TREATING PYRONIES DISEASEJanuary 2022June 2025Allow4120NoNo
17569733SURGICAL CUTTING TOOLJanuary 2022March 2025Allow3920NoNo
17564310MUSCLE STIMULATION ASSEMBLYDecember 2021May 2024Abandon2820NoNo
17622577Thin Film Mapping CatheterDecember 2021October 2024Allow3310YesNo
17558665TREATMENT DEVICE WITH DAMPING FEATUREDecember 2021October 2024Allow3410NoNo
17556638BLOOD PUMP WITH FLOW CANNULADecember 2021October 2022Allow1000NoNo
17644930PERSONALIZATION OF EXCIMER LASER FIBERSDecember 2021February 2023Allow1410NoNo
17276439STIMULATION SYSTEM WITH MONOLITHIC-LEAD COMPONENT CONNECTED TO SKULL MOUNT PACKAGEDecember 2021April 2024Allow3730YesNo
17551696IMPLANT SYSTEM AND METHODDecember 2021September 2024Allow3420YesNo
17644186ENHANCED STIFFENING IMPLEMENT FOR A SURGICAL TOOLDecember 2021January 2025Allow3720NoNo
17619223Treatment of Inflammatory DisordersDecember 2021January 2024Abandon2510NoNo
17546725NEUROMODULATION PROBEDecember 2021July 2023Allow1910NoNo
17457961INSULATED ELECTRODE FOR DELIVERING TUMOR TREATING ELECTROMAGNETIC FIELDSDecember 2021May 2023Allow1710NoNo
17615125CRYO-ABLATION CATHETERNovember 2021November 2024Abandon3610NoNo
17529967MULTI-CABLE MEDICAL INSTRUMENTNovember 2021November 2023Allow2410YesNo
17523927MUSCLE STIMULATION APPARATUS AND MUSCLE STIMULATION SYSTEM THEREOFNovember 2021October 2023Allow2310NoNo
17522612SEGMENTED LEAD INDEPENDENT ELECTRODE CONTROL FOR SENSING OR ADAPTIVE STIMULATIONNovember 2021April 2024Allow3010NoNo
17609388Electrical Stimulation DeviceNovember 2021February 2024Allow2820NoNo
17515683PERCUTANEOUS COILED CATHETER DESIGN FOR GALLBLADDER CRYOABLATIONNovember 2021June 2024Allow3110YesNo
17598664SPORTSWEAR CAPABLE OF PROVIDING ELECTRICAL STIMULATIONSeptember 2021September 2024Abandon3510NoNo
17484267LIGHT BRUSH AND METHOD OF USESeptember 2021January 2023Allow1610YesNo
17439039IMPLANTABLE ULTRASONIC DEVICESeptember 2021April 2024Allow3110NoNo
17472652Therapeutic devices and methods to improve body functionsSeptember 2021January 2024Abandon2820NoNo
17469793DBS Lead Fixation Devices Having a Clamp and/or Peripheral Lead Retention GroovesSeptember 2021June 2025Allow4501NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SOLOMON, JOSHUA BRENDON.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
0
(0.0%)
Examiner Reversed
1
(100.0%)
Reversal Percentile
99.7%
Higher than average

What This Means

With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
7
Allowed After Appeal Filing
3
(42.9%)
Not Allowed After Appeal Filing
4
(57.1%)
Filing Benefit Percentile
69.3%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 42.9% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner SOLOMON, JOSHUA BRENDON - Prosecution Strategy Guide

Executive Summary

Examiner SOLOMON, JOSHUA BRENDON works in Art Unit 3792 and has examined 243 patent applications in our dataset. With an allowance rate of 82.7%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 29 months.

Allowance Patterns

Examiner SOLOMON, JOSHUA BRENDON's allowance rate of 82.7% places them in the 49% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by SOLOMON, JOSHUA BRENDON receive 1.67 office actions before reaching final disposition. This places the examiner in the 47% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by SOLOMON, JOSHUA BRENDON is 29 months. This places the examiner in the 49% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +18.4% benefit to allowance rate for applications examined by SOLOMON, JOSHUA BRENDON. This interview benefit is in the 65% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 36.6% of applications are subsequently allowed. This success rate is in the 80% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 36.0% of cases where such amendments are filed. This entry rate is in the 46% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 100% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 85.7% of appeals filed. This is in the 77% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 34.8% are granted (fully or in part). This grant rate is in the 30% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 44% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 43% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.